Is Heartburn a Side Effect of Wegovy? What the Evidence Shows

Heartburn and acid reflux are listed side effects of semaglutide (Wegovy), caused largely by the medicine's slowing of stomach emptying.
Symptoms are most likely to appear after starting treatment or following a dose increase, and often ease within days to a couple of weeks.
Certain foods, meal sizes and lying down soon after eating can make reflux worse on Wegovy, adjusting habits often helps.
Severe or persistent stomach pain that spreads to the back is a different, more serious signal that needs prompt medical attention.

Yes, heartburn is a recognised side effect of Wegovy. Semaglutide slows gastric emptying, which can allow stomach acid to linger longer than usual and increase reflux symptoms in some people. The NHS semaglutide medicines page lists indigestion and reflux among the known gastrointestinal effects, and clinical trial data from the STEP programme confirmed that upper-GI symptoms — including heartburn-type discomfort — affected a meaningful proportion of participants. These are prescription-only medicines; a GPhC-registered prescriber assesses whether they are suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide causes reflux, and what you can do about it

What trial data and official guidance actually say about Wegovy and heartburn

The STEP 1 trial, published in the New England Journal of Medicine, enrolled more than 1,900 adults and systematically recorded gastrointestinal events throughout 68 weeks of treatment. Upper-GI symptoms (indigestion, acid reflux, belching and nausea) were among the most commonly reported effects, particularly in the weeks following each dose step. The trial found these were generally mild to moderate and transient rather than persistent, though a small number of participants did discontinue because of GI effects.

The Wegovy prescribing information and the NHS semaglutide guidance both categorise gastro-oesophageal reflux disease (GORD) and dyspepsia as known effects. If you want to understand whether Wegovy gives you heartburn and why it happens, it helps to know that heartburn is the everyday name for the burning sensation caused by stomach acid travelling upward into the oesophagus, exactly the pattern that a slower-emptying stomach can encourage. So if you notice that burning feeling behind the breastbone after starting or increasing Wegovy, the medicine is a plausible cause rather than a coincidence.

For a broader picture of all reported side effects across the trial programme, the Wegovy side effects overview on this site brings together what is known in one place.

Why slowed gastric emptying sits at the heart of the problem

Semaglutide works partly by slowing how quickly food moves from the stomach into the small intestine. That delay is useful for reducing appetite and moderating blood-sugar rises, but it also means food (and acid) spend longer in the stomach. The lower oesophageal sphincter, the valve between the stomach and gullet, can be challenged by that extended residency, particularly after larger meals or when lying flat.

The mechanism explains a practical checking habit worth building: before bed, sit upright for at least two to three minutes and think back over the evening meal, portion size, whether it was fatty or spicy, how quickly it was eaten. Reflux on Wegovy frequently traces back to one of those variables, and identifying the pattern is usually straightforward. Smaller meals, slower eating and avoiding lying down within two to three hours of eating are the adjustments that patients most commonly find useful.

If you are curious how heartburn specifically compares to the broader reflux picture people report, the dedicated Wegovy heartburn page goes into more practical detail on what to expect.

When heartburn shades into something that requires medical attention

Ordinary reflux discomfort is uncomfortable but not dangerous. There are, however, symptoms that should prompt you to seek medical help promptly rather than managing at home.

In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines including semaglutide. The distinguishing feature is severe, persistent stomach pain that radiates toward the back, with or without vomiting. That pattern is meaningfully different from the familiar burning of heartburn and needs urgent assessment, do not assume it is ordinary reflux and wait for it to pass.

Other signals worth acting on promptly: pain that is getting steadily worse rather than settling, difficulty swallowing, vomiting that continues for more than a day or two, or any sign of dehydration. Stopping Wegovy without speaking to your prescriber is rarely the right first step; the question of stopping Wegovy suddenly is worth reading if you are weighing that option. If you experience something unexpected and want a professional view, you can also contact our team directly through our support page.

Suspected side effects can also be reported through the MHRA Yellow Card scheme, the reporting system exists partly so that regulators can detect patterns that emerge at scale in real-world use.

Practical steps, and when to speak to a prescriber

For most people, reflux on Wegovy is manageable without stopping treatment. Eating smaller portions, chewing slowly, reducing fatty or acidic foods, and keeping the head slightly elevated in bed are all worth trying before concluding that the medicine cannot be tolerated. Fatigue sometimes accompanies the same GI phase; it is reassuring that fatigue on Wegovy tends to follow the same settling pattern as digestive symptoms.

If symptoms are severe, lasting more than two weeks, or genuinely affecting quality of life, a conversation with your prescriber is the right move. They can consider whether an over-the-counter antacid is appropriate alongside treatment, whether the dose progression should be slowed, or whether a different approach is warranted. Context matters: your full medical picture, any other medicines you take, and how long you have been at the current dose all shape that decision.

If you are exploring Wegovy and want to understand the full cost picture before starting, the Wegovy cost page sets out what private treatment typically involves in the UK. When you are ready to take the next step, speak to our prescribers through a free consultation, a named GPhC-registered clinician reads your answers and responds the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions